cost effectiveness analysis
Advertisement
health

What Are the Hidden Costs in Health Care Decisions?

December 1, 2025

Over the past decade, health economists have been paying more attention to the bigger picture when evaluating the value of medical treatments. A recent study looked at nearly 8, 000 cost-effectiveness analyses (CEAs) from 2013 to 2023. These studies compare the costs and benefits of different health

health

Gonorrhea Vaccine Rollout: Finding the Best Way to Reach Those in Need

June 22, 2025

Gonorrhea is a big problem among men who have sex with men (MSM) in the UK. A vaccine could help, but how do we make sure it reaches the right people without breaking the bank? This is a tricky question. Some methods have been tried before, but they have their issues. For example, giving the vaccine

health

Flu's Heavy Toll: Should France Vaccinate More Adults?

June 8, 2025

Every year, influenza sweeps through France, leading to over 1 million visits to doctors, 20, 000 hospital stays, and sadly, around 9, 000 deaths. This virus doesn't discriminate, but it does hit some groups harder than others. Adults aged 50 and over are at a higher risk. Why? As people age, they o

health

The Price of Genetic Insights

June 8, 2025

The 100, 000 Genomes Project is a big deal in the world of genetics. It's all about sequencing genomes to find extra bits of information. This isn't just about finding out what makes us unique. It's also about discovering health risks that people might not know they have. But there's a catch. Return

health

Point-of-Care TB Testing: A Game Changer in Africa?

May 31, 2025

In many developing countries, tuberculosis (TB) often goes undetected or is diagnosed too late. This delay leads to unnecessary suffering, deaths, and further spread of the disease. One promising solution is decentralized testing, which brings accurate TB diagnosis closer to where people live. The T

health

Nirsevimab: A Smart Way to Fight RSV in Shanghai Babies

May 20, 2025

In January 2024, Chinese officials gave the green light to nirsevimab. This drug is designed to shield infants from respiratory syncytial virus (RSV). In Shanghai, researchers wanted to see if using nirsevimab for babies was a good deal. They looked at two plans: giving the shot all year or just dur

health

Home Dialysis: Saving Lives and Money

May 4, 2025

Let's dive into the world of kidney disease treatment. Two main options exist for people with failing kidneys: home dialysis and in-center dialysis. Home dialysis, done daily, has some clear benefits. It can improve a person's quality of life and offer more flexibility in scheduling. However, the co

health

Laser Tonsillotomy Versus Tonsillectomy: What's the Better Deal?

April 29, 2025

Tonsil issues in adults can be a real pain. For years, the go-to fix has been a tonsillectomy. This is where doctors remove the tonsils completely. But recovery can be tough. It often involves a lot of pain and time off work. So, researchers have been looking into a different approach: laser tonsill

health

Is Molnupiravir Worth the Cost for Elderly COVID-19 Patients in Japan?

April 23, 2025

Japan has been grappling with the COVID-19 pandemic, much like the rest of the world. As the virus continues to evolve, so do the treatments. One such treatment is molnupiravir. This antiviral drug has been a topic of discussion, especially when it comes to its cost-effectiveness for older adults. T

health

The Cost and Effectiveness of Treating Advanced Colorectal Cancer

April 11, 2025

Colorectal cancer is a serious health issue. It is the third most common cancer worldwide. It can be tough to treat, especially when it comes back after initial treatment, which is known as refractory colorectal cancer. Doctors have several options for treating this type of cancer. They often tu